Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review.

Ahmad SY, Friel J, Mackay D (2020) The effects of non-nutritive artificial sweeteners, aspartame and sucralose, on the Gut microbiome in healthy adults: secondary outcomes of a randomized double-blinded crossover clinical trial. Nutrients 12(11):3408. https://doi.org/10.3390/nu12113408

doi: 10.3390/nu12113408 pubmed: 33171964 pmcid: 7694690

Alasfar RH, Isaifan RJ (2021) Aluminum environmental pollution: the silent killer. Environ Sci Pollut Res Int 28(33):44587–44597. https://doi.org/10.1007/s11356-021-14700-0

doi: 10.1007/s11356-021-14700-0 pubmed: 34196863 pmcid: 8364537

Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, Sadeghi A, Nixon MR, Abdoli A, Abolhassani H et al (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5(1):17–30. https://doi.org/10.1016/S2468-1253(19)30333-4

doi: 10.1016/S2468-1253(19)30333-4

Amamou A, Rouland M, Yaker L, Goichon A, Guérin C, Aziz M, Savoye G, Marion-Letellier R (2021) Dietary salt exacerbates intestinal fibrosis in chronic TNBS colitis via fibroblasts activation. Sci Rep 11(1):15055. https://doi.org/10.1038/s41598-021-94280-8

doi: 10.1038/s41598-021-94280-8 pubmed: 34301970 pmcid: 8302708

Amirabadi HE, Donkers JM, Wierenga E, Ingenhut B, Pieters L, Stevens L, Donkers T, Westerhout J, Masereeuw R, Bobeldijk-Pastorova I et al (2022) Intestinal explant barrier chip: long-term intestinal absorption screening in a novel microphysiological system using tissue explants. Lab Chip 22(2):326–342. https://doi.org/10.1039/D1LC00669J

doi: 10.1039/D1LC00669J

Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K (2011) Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. Inflamm Bowel Dis 17(5):1138–1145. https://doi.org/10.1002/ibd.21455

doi: 10.1002/ibd.21455 pubmed: 20806342

Anderson CA, Boucher G, Lees CW, Franke A, D’Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43(3):246–252. https://doi.org/10.1038/ng.764

doi: 10.1038/ng.764 pubmed: 21297633 pmcid: 3084597

Antoniou E, Margonis GA, Angelou A, Pikouli A, Argiri P, Karavokyros I, Papalois A, Pikoulis E (2016) The TNBS-induced colitis animal model: an overview. Ann Med Surg (lond) 11:9–15. https://doi.org/10.1016/j.amsu.2016.07.019

doi: 10.1016/j.amsu.2016.07.019 pubmed: 27656280

Araki Y, Sugihara H, Hattori T (2006) In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis. Oncol Rep 16(6):1357–1362

pubmed: 17089061

Authority (EFSA) EFS (2019) Statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos. EFSA J 17(8):e05809. https://doi.org/10.2903/j.efsa.2019.5809

doi: 10.2903/j.efsa.2019.5809

Authority (EFSA) EFS, Carrasco Cabrera L, Di Piazza G, Dujardin B, Medina Pastor P (2023) The 2021 European Union report on pesticide residues in food. EFSA J 21(4):e07939. https://doi.org/10.2903/j.efsa.2023.7939

doi: 10.2903/j.efsa.2023.7939

Bancil AS, Sandall AM, Rossi M, Chassaing B, Lindsay JO, Whelan K (2021) Food Additive Emulsifiers and Their Impact on Gut Microbiome, Permeability, and Inflammation: Mechanistic Insights in Inflammatory Bowel Disease. J Crohn’s Colitis 15(6):1068–1079. https://doi.org/10.1093/ecco-jcc/jjaa254

doi: 10.1093/ecco-jcc/jjaa254

Barciela P, Perez-Vazquez A, Prieto MA (2023) Azo dyes in the food industry: features, classification, toxicity, alternatives, and regulation. Food Chem Toxicol 178:113935. https://doi.org/10.1016/j.fct.2023.113935

doi: 10.1016/j.fct.2023.113935 pubmed: 37429408

Bauer C, Duewell P, Lehr H-A, Endres S, Schnurr M (2012) Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors. Dig Dis 30(Suppl 1):82–90. https://doi.org/10.1159/000341681

doi: 10.1159/000341681 pubmed: 23075874

Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA (2009) Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 43(3):597–603. https://doi.org/10.1021/es801845a

Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF (2006) A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 101(5):993–1002. https://doi.org/10.1111/j.1572-0241.2006.00381.x

doi: 10.1111/j.1572-0241.2006.00381.x pubmed: 16696783

Bischoff SC, Mailer R, Pabst O, Weier G, Sedlik W, Li Z, Chen JJ, Murphy DL, Gershon MD (2009) Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2, 4, 6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol-Gastroint Liver Physiol 296(3):G685–G695

Biskou O, Meira de-Faria F, Walter SM, Winberg ME, Haapaniemi S, Myrelid P, Söderholm JD, Keita ÅV. (2022) Increased Numbers of Enteric Glial Cells in the Peyer’s Patches and Enhanced Intestinal Permeability by Glial Cell Mediators in Patients with Ileal Crohn’s Disease. Cells 11(3):335. https://doi.org/10.3390/cells11030335

doi: 10.3390/cells11030335 pubmed: 35159145 pmcid: 8833935

Bitton A, Dobkin PL, Edwardes MD, Sewitch MJ, Meddings JB, Rawal S, Cohen A, Vermeire S, Dufresne L, Franchimont D, Wild GE (2008) Predicting relapse in Crohn’s disease: a biopsychosocial model. Gut 57(10):1386–1392. https://doi.org/10.1136/gut.2007.134817

doi: 10.1136/gut.2007.134817 pubmed: 18390994

Bovard D, Iskandar A, Luettich K, Hoeng J, Peitsch MC (2017) Organs-on-a-chip: a new paradigm for toxicological assessment and preclinical drug development. Toxicol Res Appl 1:2397847317726351. https://doi.org/10.1177/2397847317726351

doi: 10.1177/2397847317726351

Brand S (2009) Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut 58(8):1152–1167. https://doi.org/10.1136/gut.2008.163667

doi: 10.1136/gut.2008.163667 pubmed: 19592695

Bredeck G, Busch M, Rossi A, Stahlmecke B, Fomba KW, Herrmann H, Schins RPF (2023) Inhalable Saharan dust induces oxidative stress, NLRP3 inflammasome activation, and inflammatory cytokine release. Environ Int 172:107732. https://doi.org/10.1016/j.envint.2023.107732

doi: 10.1016/j.envint.2023.107732 pubmed: 36680803

Busch M, Bredeck G, Kämpfer AAM, Schins RPF (2021) Investigations of acute effects of polystyrene and polyvinyl chloride micro- and nanoplastics in an advanced in vitro triple culture model of the healthy and inflamed intestine. Environ Res 193:110536. https://doi.org/10.1016/j.envres.2020.110536

doi: 10.1016/j.envres.2020.110536 pubmed: 33253701

Busch M, Bredeck G, Waag F, Rahimi K, Ramachandran H, Bessel T, Barcikowski S, Herrmann A, Rossi A, Schins RPF (2022a) Assessing the NLRP3 inflammasome activating potential of a large panel of micro- and nanoplastics in THP-1 cells. Biomolecules 12(8):1095. https://doi.org/10.3390/biom12081095

doi: 10.3390/biom12081095 pubmed: 36008988 pmcid: 9406042

Busch M, Ramachandran H, Wahle T, Rossi A, Schins RPF (2022b) Investigating the role of the NLRP3 inflammasome pathway in acute intestinal inflammation: use of THP-1 knockout cell lines in an advanced triple culture model. Front Immunol. https://doi.org/10.3389/fimmu.2022.898039

doi: 10.3389/fimmu.2022.898039 pubmed: 36275704 pmcid: 9582129

Busch M, Brouwer H, Aalderink G, Bredeck G, Kämpfer AAM, Schins RPF, Bouwmeester H (2023) Investigating nanoplastics toxicity using advanced stem cell-based intestinal and lung in vitro models. Front Toxicol [Internet]. [accessed 2024 Mar 13] 5. https://doi.org/10.3389/ftox.2023.1112212

Cano PM, Seeboth J, Meurens F, Cognie J, Abrami R, Oswald IP, Guzylack-Piriou L (2013) Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging hypothesis through possible modulation of Th17-mediated Response. PLoS ONE 8(1):e53647. https://doi.org/10.1371/journal.pone.0053647

doi: 10.1371/journal.pone.0053647 pubmed: 23326479 pmcid: 3542340

Chandrasekaran R, Lacy DB (2017) The role of toxins in Clostridium difficile infection. FEMS Microbiol Rev 41(6):723–750

doi: 10.1093/femsre/fux048 pubmed: 29048477 pmcid: 5812492

Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT (2015) Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519(7541):92–96. https://doi.org/10.1038/nature14232

doi: 10.1038/nature14232 pubmed: 25731162 pmcid: 4910713

Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M (2014) Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 104:Unit-15.25. https://doi.org/10.1002/0471142735.im1525s104

Chen KG, Mallon BS, McKay RDG, Robey PG (2014) Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell 14(1):13–26. https://doi.org/10.1016/j.stem.2013.12.005

doi: 10.1016/j.stem.2013.12.005 pubmed: 24388173 pmcid: 3915741

Chen H, Zhao R, Wang B, Cai C, Zheng L, Wang H, Wang M, Ouyang H, Zhou X, Chai Z et al (2017) The effects of orally administered Ag, TiO2 and SiO2 nanoparticles on gut microbiota composition and colitis induction in mice. NanoImpact 8:80–88. https://doi.org/10.1016/j.impact.2017.07.005

doi: 10.1016/j.impact.2017.07.005

Chen D, Parks CG, Hofmann JN, Beane Freeman LE, Sandler DP (2024) Pesticide use and inflammatory bowel disease in licensed pesticide applicators and spouses in the Agricultural Health Study. Environ Res 249:118464. https://doi.org/10.1016/j.envres.2024.118464

doi: 10.1016/j.envres.2024.118464 pubmed: 38354883

Chen X, Wang S, Mao X, Xiang X, Ye S, Chen J, Zhu A, Meng Y, Yang X, Peng S et al. (2023) Adverse health effects of emerging contaminants on inflammatory bowel disease. Front Public Health. https://doi.org/10.3389/fpubh.2023.1140786

Cherwin AE, Templeton HN, Ehrlich AT, Patlin BH, Henry CS, Tobet SA (2023) Microfluidic organotypic device to test intestinal mucosal barrier permeability ex vivo. Lab Chip 23(18):4126–4133. https://doi.org/10.1039/D3LC00615H

doi: 10.1039/D3LC00615H pubmed: 37655621 pmcid: 10498942

Chiocchetti GM, Vélez D, Devesa V (2019) Inorganic arsenic causes intestinal barrier disruption. Metallomics 11(8):1411–1418. https://doi.org/10.1039/C9MT00144A

doi: 10.1039/C9MT00144A pubmed: 31313790

Choi E-K, Aring L, Das NK, Solanki S, Inohara N, Iwase S, Samuelson LC, Shah YM, Seo YA (2020) Impact of dietary manganese on experimental colitis in mice. FASEB J 34(2):2929–2943. https://doi.org/10.1096/fj.201902396R

doi: 10.1096/fj.201902396R pubmed: 31908045

Choi T-Y, Choi T-I, Lee Y-R, Choe S-K, Kim C-H (2021) Zebrafish as an animal model for biomedical research. Exp Mol Med 53(3):310–317. https://doi.org/10.1038/s12276-021-00571-5

doi: 10.1038/s12276-021-00571-5 pubmed: 33649498 pmcid: 8080808

Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM (2004) Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126(7):1657–1664

doi: 10.1053/j.gastro.2004.03.013 pubmed: 15188158

Coates M, Tekin I, Vrana K, Mawe G (2017) the many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease. Aliment Pharmacol Ther 46(6):569–580

doi: 10.1111/apt.14226 pubmed: 28737264

Cominelli F, Arseneau KO, Rodriguez-Palacios A, Pizarro TT (2017) Uncovering pathogenic mechanisms of inflammatory bowel disease using mouse models of Crohn’s disease-like ileitis: what is the right model? Cell Mol Gastroenterol Hepatol 4(1):19–32. https://doi.org/10.1016/j.jcmgh.2017.02.010

doi: 10.1016/j.jcmgh.2017.02.010 pubmed: 28560286 pmcid: 5439236

Coward S, Benchimol EI, Bernstein CN, Avina-Zubieta A, Bitton A, Carroll MW, Cui Y, Hoentjen F, Hracs L, Jacobson K et al (2022) Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian nationwide analysis. Off J Am Coll Gastroenterol ACG. https://doi.org/10.14309/ajg.0000000000002687

d’Aldebert E, Quaranta M, Sébert M, Bonnet D, Kirzin S, Portier G, Duffas J-P, Chabot S, Lluel P, Allart S et al (2020) Characterization of human colon organoids from inflammatory bowel disease patients. Front Cell Dev Biol. https://doi.org/10.3389/fcell.2020.00363

da Costa GG, da Conceição NG, da Silva PA, Simões BFT (2022) Worldwide dietary patterns and their association with socioeconomic data: an ecological exploratory study. Glob Health 18(1):31. https://doi.org/10.1186/s12992-022-00820-w

doi: 10.1186/s12992-022-00820-w

Dawson A, Dyer C, Macfie J, Davies J, Karsai L, Greenman J, Jacobsen M (2016) A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow. Biomicrofluidics 10(6):064101. https://doi.org/10.1063/1.4964813

doi: 10.1063/1.4964813 pubmed: 27822333 pmcid: 5097047

de Oliveira MJ, Galea R, Nag R, Cummins E, Gatt R, Valdramidis V (2022) Nanoparticle food applications and their toxicity: current trends and needs in risk assessment strategies. J Food Prot 85(2):355–372. https://doi.org/10.4315/JFP-21-184

doi: 10.4315/JFP-21-184

Dekkers S, Krystek P, Peters RJB, Lankveld DPK, Bokkers BGH, van Hoeven-Arentzen PH, Bouwmeester H, Oomen AG (2011) Presence and risks of nanosilica in food products. Nanotoxicology 5(3):393–405. https://doi.org/10.3109/17435390.2010.519836

doi: 10.3109/17435390.2010.519836 pubmed: 20868236

DeLuca JA, Allred KF, Menon R, Riordan R, Weeks BR, Jayaraman A, Allred CD (2018) Bisphenol-A alters microbiota metabolites derived from aromatic amino acids and worsens disease activity during colitis. Exp Biol Med (maywood) 243(10):864–875. https://doi.org/10.1177/1535370218782139

doi: 10.1177/1535370218782139 pubmed: 29874946

Dieleman LA, Peña AS, Meuwissen SG, van RE. (1997) Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl 223:99–104

pubmed: 9200314

Djouina M, Waxin C, Leprêtre F, Tardivel M, Tillement O, Vasseur F, Figeac M, Bongiovanni A, Sebda S, Desreumaux P et al (2022) Gene/environment interaction in the susceptibility of Crohn’s disease patients to aluminum. Sci Total Environ 850:158017. https://doi.org/10.1016/j.scitotenv.2022.158017

doi: 10.1016/j.scitotenv.2022.158017 pubmed: 35973536

Donkers JM, Eslami Amirabadi H, van de Steeg E (2021) Intestine-on-a-chip: next level in vitro research model of the human intestine. Curr Opin Toxicol 25:6–14. https://doi.org/10.1016/j.cotox.2020.11.002

doi: 10.1016/j.cotox.2020.11.002

Donkers JM, Steeg E van de, Wiese M (2024) A host-microbial metabolite interaction gut-on-a-chip model of the adult human intestine demonstrates beneficial effects upon inulin treatment of gut microbiome. Microb Res Rep 3(2):null-null. https://doi.org/10.20517/mrr.2023.79

Dosh RH, Jordan-Mahy N, Sammon C, Le Maitre CL (2019) Long-term in vitro 3D hydrogel co-culture model of inflammatory bowel disease. Sci Rep 9(1):1812. https://doi.org/10.1038/s41598-019-38524-8

doi: 10.1038/s41598-019-38524-8 pubmed: 30755679 pmcid: 6372635

Dotti I, Mayorgas A, Salas A (2022) Generation of human colon organoids from healthy and inflammatory bowel disease mucosa. PLoS ONE 17(10):e0276195. https://doi.org/10.1371/journal.pone.0276195

doi: 10.1371/journal.pone.0276195 pubmed: 36301950 pmcid: 9612551

Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314(5804):1461–1463. https://doi.org/10.1126/science.1135245

doi: 10.1126/science.1135245 pubmed: 17068223 pmcid: 4410764

Eckmann L, Kagnoff MF, Fierer J (1993) Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 61(11):4569–4574. https://doi.org/10.1128/iai.61.11.4569-4574.1993

doi: 10.1128/iai.61.11.4569-4574.1993 pubmed: 8406853 pmcid: 281206

EFSA (2016) Re-evaluation of titanium dioxide (E 171) as a food additive. EFSA J 14(9):e04545. https://doi.org/10.2903/j.efsa.2016.4545

doi: 10.2903/j.efsa.2016.4545

EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), Lambré C, Barat Baviera JM, Bolognesi C, Chesson A, Cocconcelli PS, Crebelli R, Gott DM, Grob K, Lampi E, et al (2023) Re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA J 21(4):e06857. https://doi.org/10.2903/j.efsa.2023.6857

doi: 10.2903/j.efsa.2023.6857

EFSA, Younes M, Aquilina G, Castle L, Engel K-H, Fowler P, Frutos Fernandez MJ, Fürst P, Gundert-Remy U, Gürtler R, et al (2021) Safety assessment of titanium dioxide (E171) as a food additive. EFSA J 19(5):e06585. https://doi.org/10.2903/j.efsa.2021.6585

doi: 10.2903/j.efsa.2021.6585 pubmed: 33976718

Erdmann P, Bruckmueller H, Martin P, Busch D, Haenisch S, Müller J, Wiechowska-Kozlowska A, Partecke LI, Heidecke C-D, Cascorbi I (2019) Dysregulation of mucosal membrane transporters and drug-metabolizing enzymes in ulcerative colitis. J Pharm Sci 108(2):1035–1046

doi: 10.1016/j.xphs.2018.09.024 pubmed: 30267783

Ericsson AC, Franklin CL (2021) The gut microbiome of laboratory mice: considerations and best practices for translational research. Mamm Genome 32(4):239–250. https://doi.org/10.1007/s00335-021-09863-7

doi: 10.1007/s00335-021-09863-7 pubmed: 33689000 pmcid: 8295156

Estrada HQ, Patel S, Rabizadeh S, Casero D, Targan SR, Barrett RJ (2022) Development of a personalized intestinal fibrosis model using human intestinal organoids derived from induced pluripotent stem cells. Inflamm Bowel Dis 28(5):667–679. https://doi.org/10.1093/ibd/izab292

doi: 10.1093/ibd/izab292 pubmed: 34918082

Estudante M, Morais JG, Soveral G, Benet LZ (2013) Intestinal drug transporters: an overview. Adv Drug Deliv Rev 65(10):1340–1356

doi: 10.1016/j.addr.2012.09.042 pubmed: 23041352

Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP, Gleim G (2000) Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol 95(8):1949–1954

doi: 10.1111/j.1572-0241.2000.02262.x pubmed: 10950041

Flight WG, Smith A, Paisey C, Marchesi JR, Bull MJ, Norville PJ, Mutton KJ, Webb AK, Bright-Thomas RJ, Jones AM, Mahenthiralingam E (2015) Rapid detection of emerging pathogens and loss of microbial diversity associated with severe lung disease in cystic fibrosis. J Clin Microbiol 53(7):2022–2029. https://doi.org/10.1128/jcm.00432-15

doi: 10.1128/jcm.00432-15 pubmed: 25878338 pmcid: 4473198

Foong SY, Ma NL, Lam SS, Peng W, Low F, Lee BHK, Alstrup AKO, Sonne C (2020) A recent global review of hazardous chlorpyrifos pesticide in fruit and vegetables: prevalence, remediation and actions needed. J Hazard Mater 400:123006. https://doi.org/10.1016/j.jhazmat.2020.123006

doi: 10.1016/j.jhazmat.2020.123006 pubmed: 32947729

Forrest K, Symmons D, Foster P (2004) Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease? Aliment Pharmacol Ther 20(10):1035–1043

doi: 10.1111/j.1365-2036.2004.02270.x pubmed: 15569105

Fort MM, Lesley R, Davidson NJ, Menon S, Brombacher F, Leach MW, Rennick DM (2001) IL-4 exacerbates disease in a Th1 cell transfer model of colitis1. J Immunol 166(4):2793–2800. https://doi.org/10.4049/jimmunol.166.4.2793

doi: 10.4049/jimmunol.166.4.2793 pubmed: 11160346

Furr AE, Ranganathan S, Finn OJ (2010) Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease. Pediatr Dev Pathol 13(1):24–31. https://doi.org/10.2350/08-06-0479.1

doi: 10.2350/08-06-0479.1 pubmed: 19025220

Gan F, Lin Z, Tang J, Chen X, Huang K (2023) Deoxynivalenol at no-observed adverse-effect levels aggravates DSS-induced colitis through the JAK2/STAT3 signaling pathway in mice. J Agric Food Chem 71(9):4144–4152. https://doi.org/10.1021/acs.jafc.3c00252

doi: 10.1021/acs.jafc.3c00252 pubmed: 36847760

Gangemi S, Gofita E, Costa C, Teodoro M, Briguglio G, Nikitovic D, Tzanakakis G, Tsatsakis AM, Wilks MF, Spandidos DA, Fenga C (2016) Occupational and environmental exposure to pesticides and cytokine pathways in chronic diseases (Review). Int J Mol Med 38(4):1012–1020. https://doi.org/10.3892/ijmm.2016.2728

doi: 10.3892/ijmm.2016.2728 pubmed: 27600395 pmcid: 5029960

Geiss T, Schaefert RM, Berens S, Hoffmann P, Gauss A (2018) Risk of depression in patients with inflammatory bowel disease. J Dig Dis 19(8):456–467

doi: 10.1111/1751-2980.12644 pubmed: 29989345

Gijzen L, Marescotti D, Raineri E, Nicolas A, Lanz HL, Guerrera D, van Vught R, Joore J, Vulto P, Peitsch MC et al (2020) An intestine-on-a-chip model of plug-and-play modularity to study inflammatory processes. SLAS Technol: Transl Life Sci Innovat 25(6):585–597. https://doi.org/10.1177/2472630320924999

doi: 10.1177/2472630320924999

Gong D, Gong X, Wang L, Yu X, Dong Q (2016) Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterology Research and Practice 2016:e6951091. https://doi.org/10.1155/2016/6951091

doi: 10.1155/2016/6951091

Goodhart GL (1977) Effect of aminoglycosides on the chemotactic response of human polymorphonuclear leukocytes. Antimicrob Agents Chemother 12(4):540–542. https://doi.org/10.1128/AAC.12.4.540

doi: 10.1128/AAC.12.4.540 pubmed: 921250 pmcid: 429962

Grouls M, Janssen AWF, Duivenvoorde LPM, Hooiveld GJEJ, Bouwmeester H, van der Zande M (2022) Differential gene expression in iPSC-derived human intestinal epithelial cell layers following exposure to two concentrations of butyrate, propionate and acetate. Sci Rep 12(1). https://doi.org/10.1038/s41598-022-17296-8

Gunasekera DC, Ma J, Vacharathit V, Shah P, Ramakrishnan A, Uprety P, Shen Z, Sheh A, Brayton CF, Whary MT et al (2020) The development of colitis in Il10−/− mice is dependent on IL-22. Mucosal Immunol 13(3):493–506. https://doi.org/10.1038/s41385-019-0252-3

doi: 10.1038/s41385-019-0252-3 pubmed: 31932715 pmcid: 7566780

Guo M, Liu X, Tan Y, Kang F, Zhu X, Fan X, Wang C, Wang R, Liu Y, Qin X et al (2021) Sucralose enhances the susceptibility to dextran sulfate sodium (DSS) induced colitis in mice with changes in gut microbiota. Food Funct 12(19):9380–9390. https://doi.org/10.1039/D1FO01351C

doi: 10.1039/D1FO01351C pubmed: 34606537

Guo A, Ludvigsson J, Brantsæter AL, Klingberg S, Östensson M, Størdal K, Mårild K (2024) Early-life diet and risk of inflammatory bowel disease: a pooled study in two Scandinavian birth cohorts. Gut 73(4):590–600. https://doi.org/10.1136/gutjnl-2023-330971

doi: 10.1136/gutjnl-2023-330971 pubmed: 38290832

Halter F, Tarnawski A, Schmassmann A, Peskar B (2001) Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut 49(3):443–453

doi: 10.1136/gut.49.3.443 pubmed: 11511570 pmcid: 1728453

Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39(2):207–211. https://doi.org/10.1038/ng1954

doi: 10.1038/ng1954 pubmed: 17200669

Hanyang L, Xuanzhe L, Xuyang C, Yujia Q, Jiarong F, Jun S, Zhihua R (2017) Application of zebrafish models in inflammatory bowel disease. Front Immunol 8:501. https://doi.org/10.3389/fimmu.2017.00501

doi: 10.3389/fimmu.2017.00501 pubmed: 28515725 pmcid: 5413514

Haub S, Ritze Y, Bergheim I, Pabst O, Gershon M, Bischoff S (2010) Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter. Neurogastroenterol Motil 22(7):826-e229

doi: 10.1111/j.1365-2982.2010.01479.x pubmed: 20219086 pmcid: 3063458

He Z, Chen L, Catalan-Dibene J, Bongers G, Faith JJ, Suebsuwong C, DeVita RJ, Shen Z, Fox JG, Lafaille JJ et al (2021) Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23. Cell Metab 33(7):1358-1371.e5. https://doi.org/10.1016/j.cmet.2021.04.015

doi: 10.1016/j.cmet.2021.04.015 pubmed: 33989521 pmcid: 8266754

Hentschel V, Seufferlein T, Armacki M (2021) Intestinal organoids in coculture: redefining the boundaries of gut mucosa ex vivo modeling. Am J Physiol-Gastroint Liver Physiol 321(6):G693–G704. https://doi.org/10.1152/ajpgi.00043.2021

doi: 10.1152/ajpgi.00043.2021

Hirt N, Body-Malapel M (2020) Immunotoxicity and intestinal effects of nano- and microplastics: a review of the literature. Part Fibre Toxicol 17(1):57. https://doi.org/10.1186/s12989-020-00387-7

doi: 10.1186/s12989-020-00387-7 pubmed: 33183327 pmcid: 7661204

Hoffmann P, Burmester M, Langeheine M, Brehm R, Empl MT, Seeger B, Breves G (2021) Caco-2/HT29-MTX co-cultured cells as a model for studying physiological properties and toxin-induced effects on intestinal cells. PLoS ONE 16(10):e0257824. https://doi.org/10.1371/journal.pone.0257824

doi: 10.1371/journal.pone.0257824 pubmed: 34618824 pmcid: 8496855

Hongsibsong S, Prapamontol T, Xu T, Hammock BD, Wang H, Chen Z-J, Xu Z-L (2020) Monitoring of the organophosphate pesticide chlorpyrifos in vegetable samples from local markets in Northern Thailand by developed immunoassay. Int J Environ Res Public Health 17(13):4723. https://doi.org/10.3390/ijerph17134723

doi: 10.3390/ijerph17134723 pubmed: 32630084 pmcid: 7369984

Huang H-M, Pai M-H, Liu J-J, Yeh S-L, Hou Y-C (2019) Effects of dietary exposure to chlorpyrifos on immune cell populations and inflammatory responses in mice with dextran sulfate sodium-induced colitis. Food Chem Toxicol 131:110596. https://doi.org/10.1016/j.fct.2019.110596

doi: 10.1016/j.fct.2019.110596 pubmed: 31226429

Huang H-M, Pai M-H, Yeh S-L, Hou Y-C (2020) Dietary exposure to chlorpyrifos inhibits the polarization of regulatory T cells in C57BL/6 mice with dextran sulfate sodium-induced colitis. Arch Toxicol 94(1):141–150. https://doi.org/10.1007/s00204-019-02615-2

doi: 10.1007/s00204-019-02615-2 pubmed: 31807802

Hunt JJ, Ballard JD (2013) Variations in virulence and molecular biology among emerging strains of clostridium difficile. Microbiol Mol Biol Rev 77(4):567–581. https://doi.org/10.1128/mmbr.00017-13

doi: 10.1128/mmbr.00017-13 pubmed: 24296572 pmcid: 3973386

Hviid A, Svanström H, Frisch M (2011) Antibiotic use and inflammatory bowel diseases in childhood. Gut 60(1):49–54

doi: 10.1136/gut.2010.219683 pubmed: 20966024

Ingber DE (2022) Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet 23(8):467–491. https://doi.org/10.1038/s41576-022-00466-9

doi: 10.1038/s41576-022-00466-9 pubmed: 35338360 pmcid: 8951665

Jacobse J, Li J, Rings EHHM, Samsom JN, Goettel JA (2021) Intestinal regulatory t cells as specialized tissue-restricted immune cells in intestinal immune homeostasis and disease. Front Immunol. https://doi.org/10.3389/fimmu.2021.716499

Jahnel J, Fickert P, Hauer AC, Högenauer C, Avian A, Trauner M (2014) Inflammatory bowel disease alters intestinal bile acid transporter expression. Drug Metab Dispos 42(9):1423–1431

doi: 10.1124/dmd.114.058065 pubmed: 24965812

Jelinsky SA, Derksen M, Bauman E, Verissimo CS, van Dooremalen WTM, Roos JL, Higuera Barón C, Caballero-Franco C, Johnson BG, Rooks MG et al (2023) Molecular and functional characterization of human intestinal organoids and monolayers for modeling epithelial barrier. Inflamm Bowel Dis 29(2):195–206. https://doi.org/10.1093/ibd/izac212

doi: 10.1093/ibd/izac212 pubmed: 36356046

Jess T, Rungoe C, Peyrin-Biroulet L (2012) Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies. Clin Gastroenterol Hepatol 10(6):639–645. https://doi.org/10.1016/j.cgh.2012.01.010

doi: 10.1016/j.cgh.2012.01.010 pubmed: 22289873

Johansson MEV, Gustafsson JK, Holmén-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjövall H, Hansson GC (2014) Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63(2):281–291. https://doi.org/10.1136/gutjnl-2012-303207

doi: 10.1136/gutjnl-2012-303207 pubmed: 23426893

Jones BJ, Blackburn TP (2002) The medical benefit of 5-HT research. Pharmacol Biochem Behav 71(4):555–568

doi: 10.1016/S0091-3057(01)00745-6 pubmed: 11888547

Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S (2011) Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut 60(5):631–637. https://doi.org/10.1136/gut.2010.223263

doi: 10.1136/gut.2010.223263 pubmed: 21209126

Joshi A, Soni A, Acharya S (2022) In vitro models and ex vivo systems used in inflammatory bowel disease. In Vitro Models 1(3):213–227. https://doi.org/10.1007/s44164-022-00017-w

doi: 10.1007/s44164-022-00017-w pubmed: 37519330 pmcid: 9036838

Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Philip Schumm L, Sharma Y, Anderson CA et al (2012) Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491(7422):119–124. https://doi.org/10.1038/nature11582

doi: 10.1038/nature11582 pubmed: 23128233 pmcid: 3491803

Jr CAJ, Travers P, Walport M, Shlomchik MJ Jr, Travers P, Walport M, Shlomchik MJ (2001) Immunobiology, 5th edn. Garland Science, New York

Kämpfer AAM, Urbán P, Gioria S, Kanase N, Stone V, Kinsner-Ovaskainen A (2017) Development of an in vitro co-culture model to mimic the human intestine in healthy and diseased state. Toxicol in Vitro 45:31–43. https://doi.org/10.1016/j.tiv.2017.08.011

doi: 10.1016/j.tiv.2017.08.011 pubmed: 28807632 pmcid: 5744654

Kämpfer AAM, Urbán P, La Spina R, Jiménez IO, Kanase N, Stone V, Kinsner-Ovaskainen A (2020) Ongoing inflammation enhances the toxicity of engineered nanomaterials: application of an in vitro co-culture model of the healthy and inflamed intestine. Toxicol in Vitro 63:104738. https://doi.org/10.1016/j.tiv.2019.104738

doi: 10.1016/j.tiv.2019.104738 pubmed: 31760064 pmcid: 6961208

Kämpfer AAM, Shah U-K, Chu SL, Busch M, Büttner V, He R, Rothen-Rutishauser B, Schins RPF, Jenkins GJ (2022) Interlaboratory comparison of an intestinal triple culture to confirm transferability and reproducibility. In Vitro Models. https://doi.org/10.1007/s44164-022-00025-w

doi: 10.1007/s44164-022-00025-w

Kasendra M, Tovaglieri A, Sontheimer-Phelps A, Jalili-Firoozinezhad S, Bein A, Chalkiadaki A, Scholl W, Zhang C, Rickner H, Richmond CA et al (2018) Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids. Sci Rep. https://doi.org/10.1038/s41598-018-21201-7

doi: 10.1038/s41598-018-21201-7 pubmed: 29440725 pmcid: 5811607

Katinios G, Casado-Bedmar M, Walter SA, Vicario M, González-Castro AM, Bednarska O, Söderholm JD, Hjortswang H, Keita ÅV (2020) Increased colonic epithelial permeability and mucosal eosinophilia in ulcerative colitis in remission compared with irritable bowel syndrome and health. Inflamm Bowel Dis 26(7):974–984. https://doi.org/10.1093/ibd/izz328

doi: 10.1093/ibd/izz328 pubmed: 31944236 pmcid: 7301402

Kaufmann HJ, Taubin HL (1987) Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 107(4):513–516. https://doi.org/10.7326/0003-4819-107-4-513

doi: 10.7326/0003-4819-107-4-513 pubmed: 3498419

Keubler LM, Buettner M, Häger C, Bleich A (2015) A multihit model: colitis lessons from the interleukin-10–deficient mouse. Inflamm Bowel Dis 21(8):1967–1975. https://doi.org/10.1097/MIB.0000000000000468

doi: 10.1097/MIB.0000000000000468 pubmed: 26164667

Khan MA, Howden CW (2018) The role of proton pump inhibitors in the management of upper gastrointestinal disorders. Gastroenterol Hepatol (n y) 14(3):169–175

Khan AJ, Evans HE, Glass L, Khan P, Chang CT, Nair SR (1979) Abnormal neutrophil chemotaxis and random migration induced by aminoglycoside antibiotics. J Lab Clin Med 93(2):295–300

pubmed: 429840

Khanna S, Shin A, Kelly CP (2017) Management of clostridium difficile infection in inflammatory bowel disease: expert review from the clinical practice updates Committee of the AGA Institute. Clin Gastroenterol Hepatol 15(2):166–174. https://doi.org/10.1016/j.cgh.2016.10.024

doi: 10.1016/j.cgh.2016.10.024 pubmed: 28093134

Kirsner JB, Elchlepp J (1957) The production of an experimental ulcerative colitis in rabbits. Trans Assoc Am Physicians 70:102–119

pubmed: 13496119

Knight-Sepulveda K, Kais S, Santaolalla R, Abreu MT (2015) Diet and inflammatory bowel disease. Gastroenterol Hepatol (n y) 11(8):511–520

pubmed: 27118948

Koboziev I, Karlsson F, Zhang S, Grisham MB (2011) Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis 17(5):1229–1245. https://doi.org/10.1002/ibd.21557

doi: 10.1002/ibd.21557 pubmed: 21312318

Kosiewicz MM, Nast CC, Krishnan A, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Kozaiwa K, Cominelli F (2001) Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn’s disease. J Clin Invest 107(6):695–702. https://doi.org/10.1172/JCI10956

doi: 10.1172/JCI10956 pubmed: 11254669 pmcid: 208944

Kuppens IELM, Witteveen EO, Jewell RC, Radema SA, Paul EM, Mangum SG, Beijnen JH, Voest EE, Schellens JHM (2007) A phase I, randomized, open-label, parallel-cohort, dose-finding study of Elacridar (GF120918) and oral topotecan in cancer patients. Clin Cancer Res 13(11):3276–3285. https://doi.org/10.1158/1078-0432.CCR-06-2414

doi: 10.1158/1078-0432.CCR-06-2414 pubmed: 17545533

Kwon YH, Banskota S, Wang H, Rossi L, Grondin JA, Syed SA, Yousefi Y, Schertzer JD, Morrison KM, Wade MG et al (2022) Chronic exposure to synthetic food colorant Allura Red AC promotes susceptibility to experimental colitis via intestinal serotonin in mice. Nat Commun 13(1):7617. https://doi.org/10.1038/s41467-022-35309-y

doi: 10.1038/s41467-022-35309-y pubmed: 36539404 pmcid: 9768151

Lai K-P, Chung Y-T, Li R, Wan H-T, Wong CK-C (2016) Bisphenol A alters gut microbiome: comparative metagenomics analysis. Environ Pollut 218:923–930. https://doi.org/10.1016/j.envpol.2016.08.039

doi: 10.1016/j.envpol.2016.08.039 pubmed: 27554980

Laredo V, García-Mateo S, Martínez-Domínguez SJ, de la Cruz JL, Gargallo-Puyuelo CJ, Gomollón F (2023) Risk of cancer in patients with inflammatory bowel diseases and keys for patient management. Cancers 15(3):871. https://doi.org/10.3390/cancers15030871

doi: 10.3390/cancers15030871 pubmed: 36765829 pmcid: 9913122

Laudisi F, Di Fusco D, Dinallo V, Stolfi C, Di Grazia A, Marafini I, Colantoni A, Ortenzi A, Alteri C, Guerrieri F et al (2019) The food additive maltodextrin promotes endoplasmic reticulum stress-driven mucus depletion and exacerbates intestinal inflammation. Cell Mol Gastroenterol Hepatol 7(2):457–473. https://doi.org/10.1016/j.jcmgh.2018.09.002

doi: 10.1016/j.jcmgh.2018.09.002 pubmed: 30765332

Le Berre C, Ananthakrishnan AN, Danese S, Singh S, Peyrin-Biroulet L (2020) Ulcerative colitis and Crohn’s disease have similar burden and goals for treatment. Clin Gastroenterol Hepatol 18(1):14–23. https://doi.org/10.1016/j.cgh.2019.07.005

doi: 10.1016/j.cgh.2019.07.005 pubmed: 31301452

Lea T. 2015. Caco-2 Cell Line. In: Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, Requena T, Swiatecka D, Wichers H, editors (2022) The Impact of Food Bioactives on Health: in vitro and ex vivo models [Internet]. Cham (CH): Springer; [accessed 2022 Nov 30]. http://www.ncbi.nlm.nih.gov/books/NBK500149/

Lee GR (2018) The balance of Th17 versus treg cells in autoimmunity. Int J Mol Sci 19(3):730. https://doi.org/10.3390/ijms19030730

doi: 10.3390/ijms19030730 pubmed: 29510522 pmcid: 5877591

Lee T, Russell L, Deng M, Gibson PR (2013) Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in A ustralians deployed abroad. Intern Med J 43(8):919–926

doi: 10.1111/imj.12179 pubmed: 23656210

Lee C, Hong S-N, Kim E-R, Chang D-K, Kim Y-H (2021) Epithelial Regeneration Ability of Crohn’s Disease Assessed Using Patient-Derived Intestinal Organoids. Int J Mol Sci 22(11):6013. https://doi.org/10.3390/ijms22116013

doi: 10.3390/ijms22116013 pubmed: 34199463 pmcid: 8199630

Leenaars CHC, Kouwenaar C, Stafleu FR, Bleich A, Ritskes-Hoitinga M, De Vries RBM, Meijboom FLB (2019) Animal to human translation: a systematic scoping review of reported concordance rates. J Transl Med 17(1):223. https://doi.org/10.1186/s12967-019-1976-2

doi: 10.1186/s12967-019-1976-2 pubmed: 31307492 pmcid: 6631915

Leso V, Ricciardi W, Iavicoli I (2015) Occupational risk factors in inflammatory bowel disease. Eur Rev Med Pharmacol Sci 19(15):2838–2851

pubmed: 26241538

Lian P, Braber S, Varasteh S, Wichers HJ, Folkerts G (2021) Hypoxia and heat stress affect epithelial integrity in a Caco-2/HT-29 co-culture. Sci Rep 11(1):13186. https://doi.org/10.1038/s41598-021-92574-5

doi: 10.1038/s41598-021-92574-5 pubmed: 34162953 pmcid: 8222227

Liang Q, Ren X, Chalamaiah M, Ma H (2020) Simulated gastrointestinal digests of corn protein hydrolysate alleviate inflammation in caco-2 cells and a mouse model of colitis. J Food Sci Technol 57(6):2079–2088. https://doi.org/10.1007/s13197-020-04242-7

doi: 10.1007/s13197-020-04242-7 pubmed: 32431334 pmcid: 7230093

Libertucci J, Dutta U, Kaur S, Jury J, Rossi L, Fontes ME, Shajib MS, Khan WI, Surette MG, Verdu EF, Armstrong D (2018) Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn’s disease. Am J Physiol-Gastrointestal and Liver Physiology. 315(3):G420–G431. https://doi.org/10.1152/ajpgi.00411.2017

Lin X, Sun Q, Zhou L, He M, Dong X, Lai M, Liu M, Su Y, Jia C, Han Z et al (2018) Colonic epithelial mTORC1 promotes ulcerative colitis through COX-2-mediated Th17 responses. Mucosal Immunol 11(6):1663–1673. https://doi.org/10.1038/s41385-018-0018-3

doi: 10.1038/s41385-018-0018-3 pubmed: 30082707

Linares R, Fernández MF, Gutiérrez A, García-Villalba R, Suárez B, Zapater P, Martínez-Blázquez JA, Caparrós E, Tomás-Barberán FA, Francés R (2021) Endocrine disruption in Crohn’s disease: Bisphenol A enhances systemic inflammatory response in patients with gut barrier translocation of dysbiotic microbiota products. FASEB J 35(7):e21697. https://doi.org/10.1096/fj.202100481R

doi: 10.1096/fj.202100481R pubmed: 34085740

Llewellyn SR, Britton GJ, Contijoch EJ, Vennaro OH, Mortha A, Colombel J-F, Grinspan A, Clemente JC, Merad M, Faith JJ (2018) Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice. Gastroenterology 154(4):1037-1046.e2. https://doi.org/10.1053/j.gastro.2017.11.030

doi: 10.1053/j.gastro.2017.11.030 pubmed: 29174952

Loftus EV (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517. https://doi.org/10.1053/j.gastro.2004.01.063

doi: 10.1053/j.gastro.2004.01.063 pubmed: 15168363

Lombardo L, Foti M, Ruggia O, Chiecchio A (2010) Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 8(6):504–508

doi: 10.1016/j.cgh.2009.12.022 pubmed: 20060064

Lomer MCE, Harvey RSJ, Evans SM, Thompson RPH, Powell JJ (2001) Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn’s disease. Eur J Gastroenterol Hepatol 13(2):101

doi: 10.1097/00042737-200102000-00003 pubmed: 11246607

Lomer MCE, Hutchinson C, Volkert S, Greenfield SM, Catterall A, Thompson RPH, Powell JJ (2004) Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn’s disease. Br J Nutr 92(6):947–955. https://doi.org/10.1079/bjn20041276

doi: 10.1079/bjn20041276 pubmed: 15613257

Lu Y-C, Yeh W-C, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42(2):145–151. https://doi.org/10.1016/j.cyto.2008.01.006

doi: 10.1016/j.cyto.2008.01.006 pubmed: 18304834

Mahadevan U, Loftus EV Jr, Tremaine WJ, Sandborn WJ (2002) Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. Am J Gastroenterol 97(4):910–914

doi: 10.1111/j.1572-0241.2002.05608.x pubmed: 12008668

Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474(7351):298–306. https://doi.org/10.1038/nature10208

doi: 10.1038/nature10208 pubmed: 21677746

Maresca M, Fantini J (2010) Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. Toxicon 56(3):282–294. https://doi.org/10.1016/j.toxicon.2010.04.016

doi: 10.1016/j.toxicon.2010.04.016 pubmed: 20466014

Marescotti D, Lo Sasso G, Guerrera D, Renggli K, Ruiz Castro PA, Piault R, Jaquet V, Moine F, Luettich K, Frentzel S, et al. 2021. Development of an Advanced Multicellular Intestinal Model for Assessing Immunomodulatory Properties of Anti-Inflammatory Compounds. Frontiers in Pharmacology [Internet]. [accessed 2023 Oct 4] 12. https://www.frontiersin.org/articles/ https://doi.org/10.3389/fphar.2021.639716

Margolis DJ, Fanelli M, Hoffstad O, Lewis JD. 2010. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Official journal of the American College of Gastroenterology| ACG. 105(12):2610–2616.

Maria-Ferreira D, Nascimento AM, Cipriani TR, Santana-Filho AP, da Watanabe P, S, Sant´Ana D de MG, Luciano FB, Bocate KCP, van den Wijngaard RM, Werner MF de P, Baggio CH. (2018) Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells. Sci Rep 8(1):12261. https://doi.org/10.1038/s41598-018-30526-2

doi: 10.1038/s41598-018-30526-2 pubmed: 30115942 pmcid: 6095889

Marsee A, Roos FJM, Verstegen MMA, Marsee A, Roos F, Verstegen M, Clevers H, Vallier L, Takebe T, Huch M et al (2021) Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell 28(5):816–832. https://doi.org/10.1016/j.stem.2021.04.005

doi: 10.1016/j.stem.2021.04.005 pubmed: 33961769

Matsuda H, Nibe-Shirakihara Y, Tamura A, Aonuma E, Arakawa S, Otsubo K, Nemoto Y, Nagaishi T, Tsuchiya K, Shimizu S et al (2022) Nickel particles are present in Crohn’s disease tissue and exacerbate intestinal inflammation in IBD susceptible mice. Biochem Biophys Res Commun 592:74–80. https://doi.org/10.1016/j.bbrc.2021.12.111

doi: 10.1016/j.bbrc.2021.12.111 pubmed: 35032835

Matsui H, Shimokawa O, Kaneko T, Nagano Y, Rai K, Hyodo I (2011) The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine. J Clin Biochem Nutr 48(2):107–111. https://doi.org/10.3164/jcbn.10-79

doi: 10.3164/jcbn.10-79 pubmed: 21373261 pmcid: 3045681

Meerum Terwogt JM, Malingré MM, Beijnen JH, ten Bokkel Huinink WW, Rosing H, Koopman FJ, van Tellingen O, Swart M, Schellens JH (1999) Coadministration of oral cyclosporin A enables oral therapy with paclitaxel. Clin Cancer Res 5(11):3379–3384

pubmed: 10589748

Meira LB, Bugni JM, Green SL, Lee C-W, Pang B, Borenshtein D, Rickman BH, Rogers AB, Moroski-Erkul CA, McFaline JL et al (2008) DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 118(7):2516–2525. https://doi.org/10.1172/JCI35073

doi: 10.1172/JCI35073 pubmed: 18521188 pmcid: 2423313

Mesnage R, Brandsma I, Moelijker N, Zhang G, Antoniou MN (2021) Genotoxicity evaluation of 2,4-D, dicamba and glyphosate alone or in combination with cell reporter assays for DNA damage, oxidative stress and unfolded protein response. Food Chem Toxicol 157:112601. https://doi.org/10.1016/j.fct.2021.112601

doi: 10.1016/j.fct.2021.112601 pubmed: 34626751

Meyer AM, Ramzan NN, Loftus EV Jr, Heigh RI, Leighton JA (2004) The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 38(9):772–775

doi: 10.1097/01.mcg.0000139057.05297.d6 pubmed: 15365403

Monteiro CA, Moubarac J-C, Cannon G, Ng SW, Popkin B (2013) Ultra-processed products are becoming dominant in the global food system. Obes Rev 14(S2):21–28. https://doi.org/10.1111/obr.12107

doi: 10.1111/obr.12107 pubmed: 24102801

Monteiro CA, Cannon G, Levy RB, Moubarac J-C, Louzada ML, Rauber F, Khandpur N, Cediel G, Neri D, Martinez-Steele E et al (2019) Ultra-processed foods: what they are and how to identify them. Public Health Nutr 22(5):936–941. https://doi.org/10.1017/S1368980018003762

doi: 10.1017/S1368980018003762 pubmed: 30744710 pmcid: 10260459

Nakai D, Miyake M, Hashimoto A (2020) Comparison of the Intestinal Drug Permeation and Accumulation Between Normal Human Intestinal Tissues and Human Intestinal Tissues With Ulcerative Colitis. J Pharm Sci 109(4):1623–1626. https://doi.org/10.1016/j.xphs.2019.12.015

doi: 10.1016/j.xphs.2019.12.015 pubmed: 31870787

Negoro R, Takayama K, Kawai K, Harada K, Sakurai F, Hirata K, Mizuguchi H (2018) Efficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies. Stem Cell Reports 11(6):1539–1550. https://doi.org/10.1016/j.stemcr.2018.10.019

doi: 10.1016/j.stemcr.2018.10.019 pubmed: 30472010 pmcid: 6294172

Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14(5):329–342. https://doi.org/10.1038/nri3661

doi: 10.1038/nri3661 pubmed: 24751956

Nighot M, Liao P-L, Morris N, McCarthy D, Dharmaprakash V, Ullah Khan I, Dalessio S, Saha K, Ganapathy AS, Wang A (2023) Long-Term Use of Proton Pump Inhibitors Disrupts Intestinal Tight Junction Barrier and Exaggerates Experimental Colitis. Journal of Crohn’s and Colitis 17(4):565–579

doi: 10.1093/ecco-jcc/jjac168 pubmed: 36322638

Nitsche KS, Müller I, Malcomber S, Carmichael PL, Bouwmeester H (2022) Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review. Arch Toxicol 96(3):711–741. https://doi.org/10.1007/s00204-022-03234-0

doi: 10.1007/s00204-022-03234-0 pubmed: 35103818 pmcid: 8850248

Nitzan O, Elias M, Peretz A, Saliba W (2016) Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol 22(3):1078–1087. https://doi.org/10.3748/wjg.v22.i3.1078

doi: 10.3748/wjg.v22.i3.1078 pubmed: 26811648 pmcid: 4716021

Niu H, Liu S, Jiang Y, Hu Y, Li Y, He L, Xing M, Li X, Wu L, Chen Z et al (2023) Are Microplastics Toxic? A Review from Eco-Toxicity to Effects on the Gut Microbiota. Metabolites 13(6):739. https://doi.org/10.3390/metabo13060739

doi: 10.3390/metabo13060739 pubmed: 37367897 pmcid: 10304106

O’brien J, (2000) Nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease. Off J Am Coll Gastroenterol ACG 95(8):1859–1861

doi: 10.1111/j.1572-0241.2000.02241.x

Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411(6837):603–606. https://doi.org/10.1038/35079114

doi: 10.1038/35079114 pubmed: 11385577

Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB (2009) T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol-Gastrointest Liver Physiol. 296(2):G135–G146. https://doi.org/10.1152/ajpgi.90462.2008

Paschall M, Seo Y-A, Choi E (2020) Low dietary manganese levels exacerbate experimental colitis in mice. Curr Dev Nutr 4(Suppl 2):1831. https://doi.org/10.1093/cdn/nzaa067_058

doi: 10.1093/cdn/nzaa067_058 pmcid: 7259238

Pathmakanthan S, Hawkey CJ (2000) A lay doctor’s guide to the inflammatory process in the gastrointestinal tract. Postgrad Med J 76(900):611–617. https://doi.org/10.1136/pmj.76.900.611

doi: 10.1136/pmj.76.900.611 pubmed: 11009574 pmcid: 1741771

Paul MB, Schlief M, Daher H, Braeuning A, Sieg H, Böhmert L (2023) A human Caco-2-based co-culture model of the inflamed intestinal mucosa for particle toxicity studies. In Vitro Models 2(1):43–64. https://doi.org/10.1007/s44164-023-00047-y

doi: 10.1007/s44164-023-00047-y

Payros D, Ménard S, Laffitte J, Neves M, Tremblay-Franco M, Luo S, Fouche E, Snini SP, Theodorou V, Pinton P, Oswald IP (2020) The food contaminant, deoxynivalenol, modulates the Thelper/Treg balance and increases inflammatory bowel diseases. Arch Toxicol 94(9):3173–3184. https://doi.org/10.1007/s00204-020-02817-z

doi: 10.1007/s00204-020-02817-z pubmed: 32617661

Pereira C, Coelho R, Grácio D, Dias C, Silva M, Peixoto A, Lopes P, Costa C, Teixeira JP, Macedo G, Magro F (2016) DNA damage and oxidative DNA damage in inflammatory bowel disease. J Crohn’s Colitis 10(11):1316–1323. https://doi.org/10.1093/ecco-jcc/jjw088

doi: 10.1093/ecco-jcc/jjw088

Pineton de Chambrun G, Body-Malapel M, Frey-Wagner I, Djouina M, Deknuydt F, Atrott K, Esquerre N, Altare F, Neut C, Arrieta MC et al (2014) Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice. Mucosal Immunol 7(3):589–601. https://doi.org/10.1038/mi.2013.78

doi: 10.1038/mi.2013.78 pubmed: 24129165

Planting AST, Sonneveld P, van der Gaast A, Sparreboom A, van der Burg MEL, Luyten GPM, de Leeuw K, de Boer-Dennert M, Wissel PS, Jewell RC et al (2005) A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors. Cancer Chemother Pharmacol 55(1):91–99. https://doi.org/10.1007/s00280-004-0854-6

doi: 10.1007/s00280-004-0854-6 pubmed: 15565444

Puschhof J, Pleguezuelos-Manzano C, Martinez-Silgado A, Akkerman N, Saftien A, Boot C, de Waal A, Beumer J, Dutta D, Heo I, Clevers H (2021) Intestinal organoid cocultures with microbes. Nat Protoc 16(10):4633–4649. https://doi.org/10.1038/s41596-021-00589-z

doi: 10.1038/s41596-021-00589-z pubmed: 34381208

Qiu H, Sun X, Sun M, He C, Li Z, Liu Z (2014) Serum bacterial toxins are related to the progression of inflammatory bowel disease. Scand J Gastroenterol 49(7):826–833. https://doi.org/10.3109/00365521.2014.919018

doi: 10.3109/00365521.2014.919018 pubmed: 24853095

Rahman S, Ghiboub M, Donkers JM, van de Steeg E, van Tol EAF, Hakvoort TBM, de Jonge WJ (2021) The progress of intestinal epithelial models from cell lines to Gut-on-chip. Int J Mol Sci 22(24):13472. https://doi.org/10.3390/ijms222413472

doi: 10.3390/ijms222413472 pubmed: 34948271 pmcid: 8709104

Raoul P, Cintoni M, Palombaro M, Basso L, Rinninella E, Gasbarrini A, Mele MC (2022) Food Additives, a Key Environmental Factor in the Development of IBD through Gut Dysbiosis. Microorganisms 10(1):167. https://doi.org/10.3390/microorganisms10010167

doi: 10.3390/microorganisms10010167 pubmed: 35056616 pmcid: 8780106

Reinoso Webb C, den Bakker H, Koboziev I, Jones-Hall Y, Rao Kottapalli K, Ostanin D, Furr KL, Mu Q, Luo XM, Grisham MB (2018) Differential susceptibility to T cell-induced colitis in mice: role of the intestinal microbiota. Inflamm Bowel Dis 24(2):361–379. https://doi.org/10.1093/ibd/izx014

doi: 10.1093/ibd/izx014 pubmed: 29361089 pmcid: 6176899

Richardson A, Schwerdtfeger LA, Eaton D, Mclean I, Henry CS, Tobet SA (2020) A microfluidic organotypic device for culture of mammalian intestines ex vivo. Anal Methods 12(3):297–303. https://doi.org/10.1039/C9AY02038A

doi: 10.1039/C9AY02038A

Rivera-Nieves J, Bamias G, Vidrich A, Marini M, Pizarro TT, McDuffie MJ, Moskaluk CA, Cohn SM, Cominelli F (2003) Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. Gastroenterology 124(4):972–982. https://doi.org/10.1053/gast.2003.50148

doi: 10.1053/gast.2003.50148 pubmed: 12671894

Rizzello F, Spisni E, Giovanardi E, Imbesi V, Salice M, Alvisi P, Valerii MC, Gionchetti P (2019) Implications of the westernized diet in the onset and progression of IBD. Nutrients 11(5):1033. https://doi.org/10.3390/nu11051033

doi: 10.3390/nu11051033 pubmed: 31072001 pmcid: 6566788

Rodriguez-Palacios A, Harding A, Menghini P, Himmelman C, Retuerto M, Nickerson KP, Lam M, Croniger CM, McLean MH, Durum SK et al (2018) The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease-Like Ileitis. Inflamm Bowel Dis 24(5):1005–1020. https://doi.org/10.1093/ibd/izy060

doi: 10.1093/ibd/izy060 pubmed: 29554272 pmcid: 5950546

Ruiz PA, Morón B, Becker HM, Lang S, Atrott K, Spalinger MR, Scharl M, Wojtal KA, Fischbeck-Terhalle A, Frey-Wagner I et al (2017) Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut 66(7):1216–1224. https://doi.org/10.1136/gutjnl-2015-310297

doi: 10.1136/gutjnl-2015-310297 pubmed: 26848183

Sanmarco LM, Chao C-C, Wang Y-C, Kenison JE, Li Z, Rone JM, Rejano-Gordillo CM, Polonio CM, Gutierrez-Vazquez C, Piester G et al (2022) Identification of environmental factors that promote intestinal inflammation. Nature 611(7937):801–809. https://doi.org/10.1038/s41586-022-05308-6

doi: 10.1038/s41586-022-05308-6 pubmed: 36266581 pmcid: 9898826

Sarvestani SK, Signs S, Hu B, Yeu Y, Feng H, Ni Y, Hill DR, Fisher RC, Ferrandon S, DeHaan RK et al (2021) Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity. Nat Commun 12(1):262. https://doi.org/10.1038/s41467-020-20351-5

doi: 10.1038/s41467-020-20351-5 pubmed: 33431859 pmcid: 7801686

Schnur S, Wahl V, Metz JK, Gillmann J, Hans F, Rotermund K, Zäh R-K, Brück DA, Schneider M, Hittinger M (2022) Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay. In Vitro Models 1(4):365–383. https://doi.org/10.1007/s44164-022-00035-8

doi: 10.1007/s44164-022-00035-8 pubmed: 37520160 pmcid: 9630817

Schug TT, Janesick A, Blumberg B, Heindel JJ (2011) Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 127(3–5):204–215. https://doi.org/10.1016/j.jsbmb.2011.08.007

doi: 10.1016/j.jsbmb.2011.08.007 pubmed: 21899826 pmcid: 3220783

Sehgal K, Yadav D, Khanna S (2021) The interplay of Clostridioides difficile infection and inflammatory bowel disease. Therap Adv Gastroenterol 14:17562848211020284. https://doi.org/10.1177/17562848211020285

doi: 10.1177/17562848211020285 pubmed: 34104215 pmcid: 8170344

Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66(11):5224–5231

doi: 10.1128/IAI.66.11.5224-5231.1998 pubmed: 9784526 pmcid: 108652

Shafa M, Yang F, Fellner T, Rao MS, Baghbaderani BA (2018) Human-induced pluripotent stem cells manufactured using a current good manufacturing practice-compliant process differentiate into clinically relevant cells from three germ layers. Front Med. https://doi.org/10.3389/fmed.2018.00069

Shajib M, Khan W (2015) The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol 213(3):561–574

doi: 10.1111/apha.12430

Sharma A, Kumar V, Shahzad B, Tanveer M, Sidhu GPS, Handa N, Kohli SK, Yadav P, Bali AS, Parihar RD et al (2019) Worldwide pesticide usage and its impacts on ecosystem. SN Appl Sci 1(11):1446. https://doi.org/10.1007/s42452-019-1485-1

doi: 10.1007/s42452-019-1485-1

Shaw SY, Blanchard JF, Bernstein CN (2010) Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 105(12):2687–2692. https://doi.org/10.1038/ajg.2010.398

doi: 10.1038/ajg.2010.398 pubmed: 20940708

Shawna Kraft P (2013) Chemotherapy-induced diarrhea: options for treatment and prevention [Internet]. https://jhoponline.com/issue-archive/2012-issues/december-2012-vol-3-no-4/15408-chemotherapy-unduced-diarrhea-options . Accessed 11 April 2024

Sheng YH, Lourie R, Lindén SK, Jeffery PL, Roche D, Tran TV, Png CW, Waterhouse N, Sutton P, Florin THJ, McGuckin MA (2011) The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut 60(12):1661–1670. https://doi.org/10.1136/gut.2011.239194

doi: 10.1136/gut.2011.239194 pubmed: 21636645

Shin W, Kim HJ (2018) Intestinal barrier dysfunction orchestrates the onset of inflammatory host–microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci 115(45):E10539–E10547. https://doi.org/10.1073/pnas.1810819115

doi: 10.1073/pnas.1810819115 pubmed: 30348765 pmcid: 6233106

Shin YC, Shin W, Koh D, Wu A, Ambrosini YM, Min S, Eckhardt SG, Fleming RYD, Kim S, Park S et al (2020) Three-Dimensional Regeneration of Patient-Derived Intestinal Organoid Epithelium in a Physiodynamic Mucosal Interface-on-a-Chip. Micromachines 11(7):663. https://doi.org/10.3390/mi11070663

doi: 10.3390/mi11070663 pubmed: 32645991 pmcid: 7408321

Shin W, Kim HJ (2022) 3D in vitro morphogenesis of human intestinal epithelium in a gut-on-a-chip or a hybrid chip with a cell culture insert. Nat Protoc 17(3):910–939. https://doi.org/10.1038/s41596-021-00674-3

doi: 10.1038/s41596-021-00674-3 pubmed: 35110737 pmcid: 9675318

Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A (2007) Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 149(3):480–486. https://doi.org/10.1111/j.1365-2249.2007.03439.x

doi: 10.1111/j.1365-2249.2007.03439.x pubmed: 17590175 pmcid: 2219317

Singh S, Blanchard A, Walker JR, Graff LA, Miller N, Bernstein CN (2011) Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin Gastroenterol Hepatol 9(9):769–775. https://doi.org/10.1016/j.cgh.2011.05.016

doi: 10.1016/j.cgh.2011.05.016 pubmed: 21645640

Singh UP, Singh NP, Murphy EA, Price RL, Fayad R, Nagarkatti M, Nagarkatti PS (2016) Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine 77:44–49. https://doi.org/10.1016/j.cyto.2015.10.008

doi: 10.1016/j.cyto.2015.10.008 pubmed: 26520877

Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4(4):277–284

doi: 10.1038/nrc1318 pubmed: 15057287

Stein A, Voigt W, Jordan K (2010) Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol 2(1):51–63. https://doi.org/10.1177/1758834009355164

doi: 10.1177/1758834009355164 pubmed: 21789126 pmcid: 3126005

Stevens LJ, van Lipzig MMH, Erpelinck SLA, Pronk A, van Gorp J, Wortelboer HM, van de Steeg E (2019) A higher throughput and physiologically relevant two-compartmental human ex vivo intestinal tissue system for studying gastrointestinal processes. Eur J Pharm Sci 137:104989. https://doi.org/10.1016/j.ejps.2019.104989

doi: 10.1016/j.ejps.2019.104989 pubmed: 31301485

Suez J, Korem T, Zilberman-Schapira G, Segal E, Elinav E (2015) Non-caloric artificial sweeteners and the microbiome: findings and challenges. Gut Microbes 6(2):149–155. https://doi.org/10.1080/19490976.2015.1017700

doi: 10.1080/19490976.2015.1017700 pubmed: 25831243 pmcid: 4615743

Susewind J, de Souza C-W, Repnik U, Collnot E-M, Schneider-Daum N, Griffiths GW, Lehr C-M (2016) A 3D co-culture of three human cell lines to model the inflamed intestinal mucosa for safety testing of nanomaterials. Nanotoxicology 10(1):53–62. https://doi.org/10.3109/17435390.2015.1008065

doi: 10.3109/17435390.2015.1008065 pubmed: 25738417

Tamargo A, Molinero N, Reinosa JJ, Alcolea-Rodriguez V, Portela R, Bañares MA, Fernández JF, Moreno-Arribas MV (2022) PET microplastics affect human gut microbiota communities during simulated gastrointestinal digestion, first evidence of plausible polymer biodegradation during human digestion. Sci Rep 12(1):528. https://doi.org/10.1038/s41598-021-04489-w

doi: 10.1038/s41598-021-04489-w pubmed: 35017590 pmcid: 8752627

Tataru C, Livni M, Marean-Reardon C, Franco MC, David M (2023) Cytokine induced inflammatory bowel disease model using organ-on-a-chip technology. PLoS ONE 18(12):e0289314. https://doi.org/10.1371/journal.pone.0289314

doi: 10.1371/journal.pone.0289314 pubmed: 38091316 pmcid: 10718466

Theochari NA, Stefanopoulos A, Mylonas KS, Economopoulos KP (2018) Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scand J Gastroenterol 53(1):1–7

doi: 10.1080/00365521.2017.1386711 pubmed: 29022402

Toutounji M, Wanes D, El-Harakeh M, El-Sabban M, Rizk S, Naim HY (2020) Dextran sodium sulfate-induced impairment of protein trafficking and alterations in membrane composition in intestinal Caco-2 cell line. Int J Mol Sci 21(8):2726. https://doi.org/10.3390/ijms21082726

doi: 10.3390/ijms21082726 pubmed: 32326391 pmcid: 7215722

Trapecar M, Communal C, Velazquez J, Maass CA, Huang Y-J, Schneider K, Wright CW, Butty V, Eng G, Yilmaz O et al (2020) Gut-Liver physiomimetics reveal paradoxical modulation of ibd-related inflammation by short-chain fatty acids. Cell Syst 10(3):223-239.e9. https://doi.org/10.1016/j.cels.2020.02.008

doi: 10.1016/j.cels.2020.02.008 pubmed: 32191873 pmcid: 8143761

Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A, Nimmo ER, Drummond H, Onnie CM, Prescott NJ et al (2007) IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 132(5):1657–1664. https://doi.org/10.1053/j.gastro.2007.02.051

doi: 10.1053/j.gastro.2007.02.051 pubmed: 17484863

Tu P, Gao B, Chi L, Lai Y, Bian X, Ru H, Lu K (2019) Subchronic low-dose 2,4-D exposure changed plasma acylcarnitine levels and induced gut microbiome perturbations in mice. Sci Rep 9(1):4363. https://doi.org/10.1038/s41598-019-40776-3

doi: 10.1038/s41598-019-40776-3 pubmed: 30867497 pmcid: 6416245

Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W et al (2021) STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160(5):1570–1583. https://doi.org/10.1053/j.gastro.2020.12.031

doi: 10.1053/j.gastro.2020.12.031 pubmed: 33359090

Ufer M, Häsler R, Jacobs G, Haenisch S, Lächelt S, Faltraco F, Sina C, Rosenstiel P, Nikolaus S, Schreiber S (2009) Decreased sigmoidal ABCB1 (P-glycoprotein) expression in ulcerative colitis is associated with disease activity. Pharmacogenomics 10(12):1941–1953

doi: 10.2217/pgs.09.128 pubmed: 19958093

Vaessen SFC, van Lipzig MMH, Pieters RHH, Krul CAM, Wortelboer HM, van de Steeg E (2017) Regional Expression Levels of Drug Transporters and Metabolizing Enzymes along the Pig and Human Intestinal Tract and Comparison with Caco-2 Cells. Drug Metab Dispos 45(4):353–360. https://doi.org/10.1124/dmd.116.072231

doi: 10.1124/dmd.116.072231 pubmed: 28153842

Van Antwerp DJ, Martin SJ, Verma IM, Green DR (1998) Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol 8(3):107–111. https://doi.org/10.1016/s0962-8924(97)01215-4

doi: 10.1016/s0962-8924(97)01215-4 pubmed: 9695819

Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G (2015) Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 21(8):1982–1992. https://doi.org/10.1097/MIB.0000000000000392

doi: 10.1097/MIB.0000000000000392 pubmed: 26154136

Verma N, Ahuja V, Paul J (2013) Profiling of ABC transporters during active ulcerative colitis and in vitro effect of inflammatory modulators. Dig Dis Sci 58:2282–2292

doi: 10.1007/s10620-013-2636-7 pubmed: 23512405

Vethaak AD, Legler J (2021) Microplastics and human health. Science 371(6530):672–674. https://doi.org/10.1126/science.abe5041

doi: 10.1126/science.abe5041 pubmed: 33574197

Vinken M (2013) The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158–165. https://doi.org/10.1016/j.tox.2013.08.011

doi: 10.1016/j.tox.2013.08.011 pubmed: 23978457

Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR (2005) Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166(2):409–419. https://doi.org/10.1016/s0002-9440(10)62264-x

doi: 10.1016/s0002-9440(10)62264-x pubmed: 15681825 pmcid: 1237049

Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, Abraham C, Turner JR (2006) IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131(4):1153–1163. https://doi.org/10.1053/j.gastro.2006.08.022

doi: 10.1053/j.gastro.2006.08.022 pubmed: 17030185

Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, Jia G, Gao Y, Li B, Sun J et al (2007) Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168(2):176–185. https://doi.org/10.1016/j.toxlet.2006.12.001

doi: 10.1016/j.toxlet.2006.12.001 pubmed: 17197136

Wang Y, DiSalvo M, Gunasekara DB, Dutton J, Proctor A, Lebhar MS, Williamson IA, Speer J, Howard RL, Smiddy NM et al (2017) Self-renewing Monolayer of Primary Colonic or Rectal Epithelial Cells. Cell Mol Gastroenterol Hepatol 4(1):165-182.e7. https://doi.org/10.1016/j.jcmgh.2017.02.011

doi: 10.1016/j.jcmgh.2017.02.011 pubmed: 29204504 pmcid: 5710741

Wang X, Guo J, Liu Y, Yu H, Qin X (2019) Sucralose increased susceptibility to colitis in rats. Inflamm Bowel Dis 25(2):e3–e4. https://doi.org/10.1093/ibd/izy196

doi: 10.1093/ibd/izy196 pubmed: 29846590

Wang S, Kang X, Alenius H, Wong SH, Karisola P, El-Nezami H (2022a) Oral exposure to Ag or TiO2 nanoparticles perturbed gut transcriptome and microbiota in a mouse model of ulcerative colitis. Food Chem Toxicol 169:113368. https://doi.org/10.1016/j.fct.2022.113368

doi: 10.1016/j.fct.2022.113368 pubmed: 36087619

Wang J, Bakker W, de Haan L, Bouwmeester H (2023) Deoxynivalenol increases pro-inflammatory cytokine secretion and reduces primary bile acid transport in an inflamed intestinal in vitro co-culture model. Food Res Int 173:113323. https://doi.org/10.1016/j.foodres.2023.113323

doi: 10.1016/j.foodres.2023.113323 pubmed: 37803634

Wang Y, Huang B, Jin T, Ocansey DKW, Jiang J, Mao F (2022) Intestinal fibrosis in inflammatory bowel disease and the prospects of mesenchymal stem cell therapy. Front Immunol 13. https://doi.org/10.3389/fimmu.2022.835005

Westerhout J, van de Steeg E, Grossouw D, Zeijdner EE, Krul CAM, Verwei M, Wortelboer HM (2014) A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices. Eur J Pharm Sci 63:167–177. https://doi.org/10.1016/j.ejps.2014.07.003

doi: 10.1016/j.ejps.2014.07.003 pubmed: 25046168

Wilkins LJ, Monga M, Miller AW (2019) Defining dysbiosis for a cluster of chronic diseases. Sci Rep 9(1):12918. https://doi.org/10.1038/s41598-019-49452-y

doi: 10.1038/s41598-019-49452-y pubmed: 31501492 pmcid: 6733864

Wilson MS, Ramalingam TR, Rivollier A, Shenderov K, Mentink-Kane MM, Madala SK, Cheever AW, Artis D, Kelsall BL, Wynn TA (2011) Colitis and Intestinal Inflammation in IL10−/− Mice Results From IL-13Rα2–Mediated Attenuation of IL-13 Activity. Gastroenterology 140(1):254-264.e2. https://doi.org/10.1053/j.gastro.2010.09.047

doi: 10.1053/j.gastro.2010.09.047 pubmed: 20951137

Wojtal KA, Eloranta JJ, Hruz P, Gutmann H, Drewe J, Staumann A, Beglinger C, Fried M, Kullak-Ublick GA, Vavricka SR (2009) Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metab Dispos 37(9):1871–1877

doi: 10.1124/dmd.109.027367 pubmed: 19487253

Workman MJ, Troisi E, Targan SR, Svendsen CN, Barrett RJ (2020) Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids. Int J Mol Sci 22(1):288. https://doi.org/10.3390/ijms22010288

doi: 10.3390/ijms22010288 pubmed: 33396621 pmcid: 7794932

Wu GD, Bushmanc FD, Lewis JD (2013) Diet, the human gut microbiota, and IBD. Anaerobe 24:117–120. https://doi.org/10.1016/j.anaerobe.2013.03.011

doi: 10.1016/j.anaerobe.2013.03.011 pubmed: 23548695

Xueting L, Liu Y, Wang Y, Xue Li, Liu X, Guo M, Tan Y, Qin X, Wang X, Jiang M (2020) Sucralose promotes colitis-associated colorectal cancer risk in a murine model along with changes in microbiota. Front Oncol. https://doi.org/10.3389/fonc.2020.00710

doi: 10.3389/fonc.2020.00710

Yakymenko O, Schoultz I, Gullberg E, Ström M, Almer S, Wallon C, Wang A, Keita ÅV, Campbell BJ, McKay DM, Söderholm JD (2018) Infliximab restores colonic barrier to adherent-invasive E. coli in Crohn’s disease via effects on epithelial lipid rafts. Scand J Gastroenterol 53(6):677–684. https://doi.org/10.1080/00365521.2018.1458146

doi: 10.1080/00365521.2018.1458146 pubmed: 29688802

Yamamoto-Furusho JK, Ascaño-Gutiérrez I, Furuzawa-Carballeda J, Fonseca-Camarillo G (2015) Differential expression of MUC12, MUC16, and MUC20 in patients with active and remission ulcerative colitis. Mediators Inflamm 2015:659018. https://doi.org/10.1155/2015/659018

doi: 10.1155/2015/659018 pubmed: 26770020 pmcid: 4684874

Yan J, Luo M, Chen Z, He B (2020) The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease. J Immunol Res 2020:e8813558. https://doi.org/10.1155/2020/8813558

doi: 10.1155/2020/8813558

Yan Z, Liu Y, Zhang T, Zhang F, Ren H, Zhang Y (2022) Analysis of microplastics in human feces reveals a correlation between fecal microplastics and inflammatory bowel disease status. Environ Sci Technol 56(1):414–421. https://doi.org/10.1021/acs.est.1c03924

doi: 10.1021/acs.est.1c03924 pubmed: 34935363

Yin F, Huang X, Lin X, Chan TF, Lai KP, Li R (2022) Analyzing the synergistic adverse effects of BPA and its substitute, BHPF, on ulcerative colitis through comparative metabolomics. Chemosphere 287:132160. https://doi.org/10.1016/j.chemosphere.2021.132160

doi: 10.1016/j.chemosphere.2021.132160 pubmed: 34509005

Yoon MY, Yoon SS (2018) Disruption of the gut ecosystem by antibiotics. Yonsei Med J 59(1):4–12

doi: 10.3349/ymj.2018.59.1.4 pubmed: 29214770

Yoshida K, Maeda K, Sugiyama Y (2013) Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms. Annu Rev Pharmacol Toxicol 53:581–612. https://doi.org/10.1146/annurev-pharmtox-011112-140309

doi: 10.1146/annurev-pharmtox-011112-140309 pubmed: 23140240

Yu YR, Rodriguez JR (2017) Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg 26(6):349–355. https://doi.org/10.1053/j.sempedsurg.2017.10.003

doi: 10.1053/j.sempedsurg.2017.10.003 pubmed: 29126502

Zallot C, Peyrin-Biroulet L (2013) Deep remission in inflammatory bowel disease: looking beyond symptoms. Curr Gastroenterol Rep 15(3):315. https://doi.org/10.1007/s11894-013-0315-7

doi: 10.1007/s11894-013-0315-7 pubmed: 23354742

Zhang L, Liu F, Xue J, Lee SA, Liu L, Riordan SM (2022) Bacterial species associated with human inflammatory bowel disease and their pathogenic mechanisms. Front Microbiol 13:801892. https://doi.org/10.3389/fmicb.2022.801892

doi: 10.3389/fmicb.2022.801892 pubmed: 35283816 pmcid: 8908260

Zhao Y, Zhang Y, Wang G, Han R, Xie X (2016) Effects of chlorpyrifos on the gut microbiome and urine metabolome in mouse (Mus musculus). Chemosphere 153:287–293. https://doi.org/10.1016/j.chemosphere.2016.03.055

doi: 10.1016/j.chemosphere.2016.03.055 pubmed: 27018521

Zhao Y, Liu S, Xu H (2023) Effects of microplastic and engineered nanomaterials on inflammatory bowel disease: a review. Chemosphere 326:138486. https://doi.org/10.1016/j.chemosphere.2023.138486

doi: 10.1016/j.chemosphere.2023.138486 pubmed: 36963581

Zhen Y, Zhang H (2019) NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. https://doi.org/10.3389/fimmu.2019.00276

doi: 10.3389/fimmu.2019.00276 pubmed: 31379844 pmcid: 6646668

Zheng H, Wang J, Wei X, Chang L, Liu S (2021) Proinflammatory properties and lipid disturbance of polystyrene microplastics in the livers of mice with acute colitis. Sci Total Environ 750:143085. https://doi.org/10.1016/j.scitotenv.2020.143085

doi: 10.1016/j.scitotenv.2020.143085 pubmed: 33182181

Zolotova N, Dzhalilova D, Tsvetkov I, Makarova O (2023) Influence of microplastics on morphological manifestations of experimental acute colitis. Toxics 11(9):730. https://doi.org/10.3390/toxics11090730

doi: 10.3390/toxics11090730 pubmed: 37755741 pmcid: 10536389

Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Subventions

Informations de copyright

Références

Auteurs

Tom Walraven (T)

Mathias Busch (M)

Jingxuan Wang (J)

Joanne M Donkers (JM)

Marjolijn Duijvestein (M)

Evita van de Steeg (E)

Nynke I Kramer (NI)

Hans Bouwmeester (H)

Classifications MeSH